Search

everythinglearnresearchcommunity

for

Search:↓

Eplerenone, a mineralocorticoid receptor antagonist, was found to promote hair growth in human hair follicles.

The dog likely has a condition similar to Canine alopecia X.

A woman with systemic sclerosis developed a unique scarring hair loss combining features of systemic sclerosis and frontal fibrosing alopecia.

Misusing topical corticosteroids can cause skin darkening and other side effects.

Some nutrients and antioxidants may improve skin and hair health, but more research is needed to confirm these benefits.

Lichen planopilaris is a rare, chronic condition causing hair loss, mainly in middle-aged women, and early treatment is important to prevent permanent baldness.

Mast cells play a significant role in hair loss conditions like male pattern hair loss and alopecia areata.

Interferon alfa-2a is effective for treating cutaneous T cell lymphoma but has significant side effects.

Estrogens can improve skin aging but carry risks; more research is needed on safer treatments.

Menopause can lead to skin and hair problems due to hormonal changes, but hormone replacement therapy might help slow these effects.

Taxane chemotherapy can cause skin, hair, and nail side effects, which are often under-reported and can affect patient quality of life.

Estrogen replacement can improve skin health in menopausal women but doesn't reverse sun damage or prevent hair loss.

Hair loss linked to higher heart disease risk in both men and women.

Nerves and chemicals in the body can affect hair growth and loss.

There are many treatments for permanent hair loss disorders, but their effectiveness varies and there's no clear best option.

Trichoscopy is a useful, non-invasive way to diagnose different types of hair loss.

Alpha-hydroxy acids, like glycolic acid, safely improve skin issues and work on all skin types.

Lichen Planopilaris and Frontal Fibrosing Alopecia may help us understand hair follicle stem cell disorders and suggest new treatments.

CCCA is a hair loss type affecting African women, possibly caused by grooming and chemicals, with various treatments and needing more research.

The document concludes that skin biopsies, genetic and environmental factors, and specific treatments are important in managing cutaneous lupus erythematosus.

The document concludes that early recognition and treatment of primary cicatricial alopecia is crucial to prevent permanent hair loss.

Graft-versus-host disease is a complication where donor immune cells attack the recipient's body, often affecting the skin, liver, and gastrointestinal tract.

Glutamine metabolism affects hair stem cell maintenance and their ability to change back to stem cells.

The document concludes that understanding and treating hair loss requires recognizing its various types and using appropriate diagnostic tools and treatments.

Hair loss is common in lupus patients and can be permanent or reversible, depending on the type, with various treatments available.

Skin symptoms are important for diagnosing and managing juvenile-onset systemic lupus erythematosus and usually get better with treatment.

Women with early hair loss have higher blood pressure and aldosterone; screening and treatment may help.

Scarring alopecias are complex hair loss disorders that require early treatment to prevent permanent hair loss.

Current and future treatments for alopecia areata focus on immunosuppression, immunomodulation, and protecting hair follicles.

A woman with subacute cutaneous lupus erythematosus had widespread skin symptoms triggered by medication and sunlight, which improved with specific treatments.